Evidence map›Paper›PMID 41841722›Full record

ArticleMicrobiology spectrum2026

Evaluation of multiple extraction and inactivation methods for the rapid identification of filamentous fungi using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Halimat Olaniyan, Chris Kendra, Alexandria Dugan, Shelby Kruer, Alisha Zuber, Jessica Bywaters, Amber Ryan, Kenneth Gavina

Abstract readEvaluation Study
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Halimat OlaniyanDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Chris KendraDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Alexandria DuganDivision of Clinical Microbiology and Serology, Eskenazi Health, Indianapolis, Indiana, USA.
Shelby KruerDivision of Clinical Microbiology and Serology, Eskenazi Health, Indianapolis, Indiana, USA.
Alisha ZuberDivision of Clinical Microbiology and Serology, Eskenazi Health, Indianapolis, Indiana, USA.
Jessica BywatersDivision of Clinical Microbiology and Serology, Eskenazi Health, Indianapolis, Indiana, USA.
Amber RyanDivision of Clinical Microbiology and Serology, Eskenazi Health, Indianapolis, Indiana, USA.
Kenneth GavinaDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.ORCID 0000-0001-8358-5611

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) offers high sensitivity for the rapid identification of microbial isolates. While predominantly used in bacterial and yeast identification within the clinical laboratory, recent advancements have prompted interest in expanding MALDI-TOF MS applications for the rapid identification of filamentous fungi, particularly clinically relevant molds. However, the implementation of mold identification protocols introduces biosafety concerns due to the potential for spore aerosolization during sample handling and inoculation, posing occupational hazards to laboratory personnel. To evaluate the feasibility and safety of MALDI-TOF MS-based mold identification, we conducted a prospective study comparing an extraction-free approach to two different rapid extraction methods across routine media and specialized fungal plates. Each method was assessed for spectral quality, reproducibility, and identification accuracy using a validated reference library. Importantly, we performed a biosafety validation study to assess the efficacy of the extraction-free approach in inactivating mold spores and hyphal elements. The extraction-free approach generally outperformed the rapid extraction methods, demonstrating more accurate fungal identifications (90.5% vs. 61.9% and 66.7%) and a higher average spectra score; accuracy and spectra scores were further enhanced using specialized fungal media (92.9% vs. 81.0% and 52.4%). Our findings support the use of this extraction-free approach as both a safe and effective method to rapidly identify filamentous fungi using MALDI-TOF MS within the clinical laboratory.IMPORTANCEThis study overviews the implementation of identifying clinically relevant filamentous fungi using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in a clinical laboratory. The methodology applied in this study produced both highly sensitive and specific results with significantly reduced turnaround time compared to traditional standard of care culture-based workup. Faster time to detection has the potential to impact the healthcare treatment of millions of patients each year without requiring significant changes to clinical workflow. This study used multiple approaches to improve the clinical utility and performance of MALDI-TOF MS for fungal identification. Importantly, it also highlights the effectiveness of a developed inactivation method to ensure laboratory personnel safety. This method and workflows are of interest to support clinical microbiology diagnostics and to help aid in infection identification to enhance timely treatment.

Indexed as

FungiSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationHumansMycological Typing TechniquesMycosesProspective StudiesReproducibility of ResultsSpores, Fungalclinical microbiologyfungal diagnosticsMALDI-TOF MSmycology

Identifiers

PMID41841722
PMCPMC13055258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.